These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35853541)

  • 1. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; García CB; Ribate MP
    Chem Biol Interact; 2022 Sep; 364():110042. PubMed ID: 35853541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of clozapine and norclozapine levels with patient and therapy characteristics-focus on interaction with valproic acid.
    Panić B; Jovanović M; Lukić V; Vučićević K; Miljković B; Milovanović S
    Eur J Clin Pharmacol; 2023 Nov; 79(11):1557-1564. PubMed ID: 37733278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders.
    Marazziti D; Palego L; Betti L; Giannaccini G; Massimetti E; Baroni S; Ciapparelli A; Lucacchini A; Mucci F; DellʼOsso L
    Ther Drug Monit; 2018 Aug; 40(4):443-451. PubMed ID: 29601407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine metabolism rate as a possible index of drug-induced granulocytopenia.
    Mauri MC; Rudelli R; Bravin S; Gianetti S; Giuliani E; Guerrini A; Orlandi R; Invernizzi G
    Psychopharmacology (Berl); 1998 Jun; 137(4):341-4. PubMed ID: 9676893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations.
    Augustin M; Schoretsanitis G; Pfeifer P; Gründer G; Liebe C; Paulzen M
    Schizophr Res; 2019 Aug; 210():143-148. PubMed ID: 31182321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
    Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
    Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
    Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
    Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia.
    Smith RL; Wollmann BM; Kyllesø L; Tran TTA; Tveito M; Molden E
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):43-50. PubMed ID: 34928560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated GC/MS method for the simultaneous determination of clozapine and norclozapine in human plasma. Application in psychiatric patients under clozapine treatment.
    Vardakou I; Dona A; Pistos C; Alevisopoulos G; Athanaselis S; Maravelias C; Spiliopoulou C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2327-32. PubMed ID: 20674521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Identification of Cysteinyl Derivatives of Toxic Clozapine Nitrenium Ions and the Effect of Valproic Acid on Metabolite Formation: A Study Using Reprocessed High-Resolution Mass Spectra of Analyzed Therapeutic Drug Monitoring Samples.
    Wollmann BM; Haugen AG; Smith RL; Molden E
    Ther Drug Monit; 2024 Apr; 46(2):265-269. PubMed ID: 38287885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
    Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
    Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
    Tsukahara M; So R; Yoshimura Y; Yamashita R; Yada Y; Kodama M; Nakajima S; Kishi Y; Takeda T; Yamada N; Takeuchi H
    Acta Psychiatr Scand; 2023 Nov; 148(5):437-446. PubMed ID: 37681448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine.
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; García CB; Ribate MP
    Per Med; 2022 May; 19(3):181-192. PubMed ID: 35259926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism.
    Smith RL; Kyllesø L; Haslemo T; Andreassen OA; Molden E
    Ther Drug Monit; 2019 Aug; 41(4):503-508. PubMed ID: 31259880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.
    Carrillo JA; Herraiz AG; Ramos SI; Benítez J
    J Clin Psychopharmacol; 1998 Aug; 18(4):311-6. PubMed ID: 9690697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity.
    Lesche D; Mostafa S; Everall I; Pantelis C; Bousman CA
    Pharmacogenomics J; 2020 Apr; 20(2):192-201. PubMed ID: 31616047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response.
    Lee ST; Ryu S; Kim SR; Kim MJ; Kim S; Kim JW; Lee SY; Hong KS
    J Clin Psychopharmacol; 2012 Aug; 32(4):441-8. PubMed ID: 22722500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Role of
    Demirbugen Oz M; Ozdemir F; Tok KC; Dural E; Kir Y; Ulusoy M; Gumustas M; Baskak B; Suzen HS
    Expert Opin Drug Metab Toxicol; 2023; 19(5):319-327. PubMed ID: 37269349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits.
    Smith RL; O'Connell K; Athanasiu L; Djurovic S; Kringen MK; Andreassen OA; Molden E
    Transl Psychiatry; 2020 Jun; 10(1):198. PubMed ID: 32555152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacometabolomics-guided clozapine therapy in treatment resistant schizophrenia: Preliminary exploration of future too near.
    Grover S; Kasudhan KS; Murali N; Patil AN; Pattanaik S; Chakrabarti S; Avasthi A
    Asian J Psychiatr; 2022 Jan; 67():102939. PubMed ID: 34844176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.